Vascular surgeon Andrew Gonzalez, MD, has been selected as the 2021–2023 National Academy of Medicine (NAM) Omenn Fellow. NAM fellowships enable talented, early-career scholars combining biomedical science and population health to participate actively in the work of the NAM and National Academies of Sciences, Engineering, and Medicine (the National Academies).
The fellowships aim to foster a cadre of physician-scientists who will integrate biomedical research, population health, and health policy and will expand the nation’s capacity for research, leadership, and policy development that advances health. The fellows will collaborate with eminent researchers, policy experts, and clinicians from across the country.
Gonzalez is the inaugural associate director for data science at the Center for Health Services Research at Regenstrief Institute and an Indiana University School of Medicine assistant professor in Indianapolis. He is studying the quality of and disparities in surgical outcomes for vulnerable populations and ways to improve them. His current early career development project seeks to apply artificial intelligence and machine learning toward optimizing outcomes and value in peripheral arterial disease.
The Omenn Fellowship is awarded for a two-year period and is one of five NAM fellowships. Gonzalez will be assigned to a board of the National Academies and participate in the board’s activities, including contributing to its reports. A flexible research grant will be awarded to every fellow.
The Gilbert S. Omenn Fellowship was established in 2012 through an endowment from Gilbert S. Omenn, MD, and Martha Darling. Omenn is a physician-scientist at the University of Michigan Medical School whose career bridges biomedical research, public health and public policy, and this fellowship reflects the integrative role that is emblematic of his professional achievements.
